Kysler Guzman

Director, CMC Regulatory Affairs at Abeona Therapeutics - New York, NY, US

Kysler Guzman's Colleagues at Abeona Therapeutics
Scott Nogi

Vice President, Business Operations

Contact Scott Nogi

Dan Rudin

Vice President

Contact Dan Rudin

Scott Arnott

Supervisor, Quality Assurance

Contact Scott Arnott

Gregory Gin

Vice President of Investor Relations

Contact Gregory Gin

Kayla Staeble

Human Resources Business Partner

Contact Kayla Staeble

Melisa Moore

Senior Manager, Clinical Quality

Contact Melisa Moore

Scott Kerns

Program Manager

Contact Scott Kerns

View All Kysler Guzman's Colleagues
Kysler Guzman's Contact Details
Email (Verified)
***@abeonatherapeutics.com
Get Kysler Guzman's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Kysler Guzman's Mobile Number
HQ
214-665-9495
Location
Grayslake,Illinois,60030,United States
Company
Abeona Therapeutics
Kysler Guzman's Company Details
Abeona Therapeutics logo, Abeona Therapeutics contact details

Abeona Therapeutics

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The Company's multi-platform expertise across the manufacture, delivery, development, and discovery of novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company's robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM™ Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery. A robust and diverse pipeline is led by a novel gene-corrected cell therapy poised to enter Phase 3 in mid-2019 and complemented by one-time gene therapy candidates across four lysosomal storage diseases. Several preclinical discoveries are led by an emerging program in cystic fibrosis that uses the AIM vector platform and a capsid that has shown potential across inherited and acquired retinal diseases.

Gene Therapy Human-derived plasma proteins Biotechnology Pharma Oncology supportive care Ovarian Cancer Alpha-1 deficiency IVIG Ultra orphan proteins Oral Mucositis Rare Disease Sanfiippo Syndrome Type A Sanfiippo Syndrome Type B MPS IIIA juvenile Batten Disease Fanconi anemia Infantile Batten Disease Epidermolysis Bullosa Lysosomal Storage Disease Cell Therapy Pediatric Rare Diseases manufacturing B2B Biotech SaaS Commercial Physical Research
Details about Abeona Therapeutics
Frequently Asked Questions about Kysler Guzman
Kysler Guzman currently works for Abeona Therapeutics.
Kysler Guzman's role at Abeona Therapeutics is Director, CMC Regulatory Affairs.
Kysler Guzman's email address is ***@abeonatherapeutics.com. To view Kysler Guzman's full email address, please signup to ConnectPlex.
Kysler Guzman works in the Research industry.
Kysler Guzman's colleagues at Abeona Therapeutics are Scott Nogi, Dan Rudin, Scott Arnott, Gregory Gin, Kayla Staeble, Melisa Moore, Scott Kerns and others.
Kysler Guzman's phone number is 214-665-9495
See more information about Kysler Guzman